Vote!

Eisai starts trials for a second Alzheimer's drug a day after Biogen failure wiped $18B off its value

Eisai said it has begun phase 3 clinical trials of Alzheimer's treatment, a day after the Japanese drugmaker and U.S. partner Biogen scrapped trials for its own Alzheimer's drug.... If you wish to read this full breaking news headline, plus more articles from around Thailand and Asia like, Eisai starts trials for a second Alzheimer's drug a day after Biogen failure wiped $18B off its value, simply click on 'Read full story' below, but 1st please give us a 'LIKE' or 'SHARE' before you leave. Thank you Eisai starts trials for a second Alzheimer's drug a day after Biogen failure wiped $18B off its value

 

 

Posted:

 

Read full story...

 

Published By: CNBC - ASIA - Friday, 22 March

 

 

Thailand News Phuket News  /  Asian Travel News South Korea - Malaysia - Singapore - China - Philippines - Laos - Burma - Cambodia - Vietnam - Indonesia

 

 

 

 

 BACK TO: Phuket Hotel Deals - Phuket Flights - Phuket Travel Articles - Phuket News - Phuket Real Estate - Asia Jobs